| First Author | Bolon I | Year | 2004 |
| Journal | Am J Pathol | Volume | 164 |
| Issue | 6 | Pages | 2299-304 |
| PubMed ID | 15161662 | Mgi Jnum | J:91071 |
| Mgi Id | MGI:3045905 | Doi | 10.1016/S0002-9440(10)63786-8 |
| Citation | Bolon I, et al. (2004) Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression. Am J Pathol 164(6):2299-304 |
| abstractText | Increased expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) is associated with different pathological conditions. Both uPAR-mediated signaling and plasmin-catalyzed extracellular proteolysis may contribute to pathogenesis. To evaluate the involvement of plasminogen in such circumstances, we have taken advantage of transgenic mouse models in which overexpression of uPA and/or uPAR in enamel epithelium, basal epidermis, and hair follicles leads to a pathological phenotype; uPA transgenic mice have chalky-white incisors and, when uPAR is co-expressed, develop extensive alopecia, epidermal thickening, and subepidermal blisters. We report here that when these transgenic mice were backcrossed into a plasminogen-deficient (Plg-/-) background, the dental and skin phenotypes appeared completely normal. Heterozygous Plg+/- transgenic mice exhibited a haplo-insufficiency, with an intermediate or normal phenotype. These results do not argue in favor of a role for uPAR-mediated signaling in our experimental model; rather, they demonstrate an essential, dose-dependent, requirement for plasminogen in uPA-mediated tissue alterations. They also support the hypothesis that plasminogen could play a part in certain skin diseases. |
